MCM
QTTB icon

Monimus Capital Management’s Q32 Bio QTTB Stock Holding History

Monimus Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Sell
132,036
-2,274
-2% -$19K 0.39% 51
2026
Q1 		$862K Buy
+134,310
New +$638K 0.24% 52

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Monimus Capital Management's QTTB Position: Q2 2026 in Review

Monimus Capital Management reduced its Q32 Bio (QTTB) stake by 1.7% in Q2 2026, selling an estimated $19K and leaving 132,036 shares worth $1.68M. The position accounts for 0.39% of the portfolio, ranked #51.

Monimus Capital Management first reported a position in QTTB in Q1 2026 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Monimus Capital Management held 132,036 shares of Q32 Bio worth $1.68M as of Q2 2026.
  • Monimus Capital Management sold 2,274 Q32 Bio shares in Q2 2026, an estimated $19K.
  • Q32 Bio made up 0.39% of Monimus Capital Management's portfolio in Q2 2026, its #51 holding.
  • Monimus Capital Management first reported a position in Q32 Bio in Q1 2026 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Monimus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.